Management options in decompensated cirrhosis

被引:13
作者
Shah, Neeral L. [1 ]
Banaei, Yasmin Pourkazemi [2 ]
Hojnowski, Kristen L. [2 ]
Cornella, Scott L. [3 ]
机构
[1] Univ Virginia, Div Gastroenterol & Hepatol, West Complex,2nd Floor,POB 800708, Charlottesville, VA 22908 USA
[2] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Med, Charlottesville, VA USA
来源
HEPATIC MEDICINE-EVIDENCE AND RESEARCH | 2015年 / 7卷
关键词
portal hypertension; hepatic encephalopathy; hepatorenal; coagulation;
D O I
10.2147/HMER.S62463
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic injury to the liver from a variety of different sources can result in irreversible scarring of the liver, known as cirrhosis. Cirrhosis is a major cause of morbidity and mortality in the USA, and according to the Centers for Disease Control and Prevention was responsible for 31,903 deaths in 2010 alone. It is thus of the utmost importance to appropriately manage these patients in the inpatient and outpatient setting to improve morbidity and mortality. In this review, we address four major areas of cirrhosis management: outpatient management of portal hypertension with decompensation, hepatic encephalopathy, hepatorenal syndrome, and bleeding/coagulation issues. Outpatient management covers recommendations for health care maintenance and screening. Hepatic encephalopathy encompasses a brief review of pathophysiology, treatment in the acute setting, and long-term prevention. Hepatorenal syndrome is discussed in regards to pathophysiology and treatment in the hospital setting. Finally, a discussion of the assessment of coagulation profiles in cirrhosis and recommendations for bleeding and thrombosis complications is included. These topics are not all encompassing with regard to this complicated population, but rather an overview of a few medical problems that are commonly encountered in their care.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 59 条
  • [1] Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials
    Als-Nielsen, B
    Gluud, LL
    Gluud, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7447): : 1046 - 1050
  • [2] Dietary management of hepatic encephalopathy revisited
    Amodio, Piero
    Canesso, Fabio
    Montagnese, Sara
    [J]. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2014, 17 (05) : 448 - 452
  • [3] MANAGEMENT OF PATIENTS WITH CIRRHOSIS AND ASCITES
    ARROYO, V
    GINES, P
    PLANAS, R
    PANES, J
    RODES, J
    [J]. SEMINARS IN LIVER DISEASE, 1986, 6 (04) : 353 - 369
  • [4] Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy
    Bosoi, Cristina R.
    Rose, Christopher F.
    [J]. METABOLIC BRAIN DISEASE, 2013, 28 (02) : 175 - 178
  • [5] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [6] PATHOGENESIS AND TREATMENT OF PORTAL SYSTEMIC ENCEPHALOPATHY - AN UPDATE
    BUTTERWORTH, RF
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (03) : 321 - 327
  • [7] THE ACCURACY OF THE PHYSICAL-EXAMINATION IN THE DIAGNOSIS OF SUSPECTED ASCITES
    CATTAU, EL
    BENJAMIN, SB
    KNUFF, TE
    CASTELL, DO
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (08): : 1164 - 1166
  • [8] Normal protein diet for episodic hepatic encephalopathy:: results of a randomized study
    Córdoba, J
    López-Hellín, J
    Planas, M
    Sabín, P
    Sanpedro, F
    Castro, F
    Esteban, R
    Guardia, J
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (01) : 38 - 43
  • [9] Polyethylene Glycol for Hepatic Encephalopathy A New Solution to Purge an Old Problem?
    Doran, Amy E.
    Shah, Neeral L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (11) : 1734 - 1735
  • [10] Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis
    Fagundes, Claudia
    Gines, Pere
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (06) : 874 - 885